nodes	percent_of_prediction	percent_of_DWPC	metapath
Carmustine—brain cancer—bone cancer	0.862	1	CtDrD
Carmustine—Lomustine—CYP3A4—bone cancer	0.00333	1	CrCbGaD
Carmustine—GSR—Nucleotide metabolism—NT5C3A—bone cancer	0.00253	0.131	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—CYP4V2—bone cancer	0.00231	0.119	CbGpPWpGaD
Carmustine—CYP1A2—Lidocaine metabolism—CYP3A4—bone cancer	0.00201	0.104	CbGpPWpGaD
Carmustine—GSR—Detoxification of Reactive Oxygen Species—GSTP1—bone cancer	0.00174	0.0901	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—BMI1—bone cancer	0.000742	0.0384	CbGpPWpGaD
Carmustine—CYP1A2—Aflatoxin B1 metabolism—CYP3A4—bone cancer	0.000738	0.0382	CbGpPWpGaD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP4V2—bone cancer	0.00066	0.0341	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—CYP3A4—bone cancer	0.000457	0.0236	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—GSTP1—bone cancer	0.000452	0.0233	CbGpPWpGaD
Carmustine—GSR—NRF2 pathway—TGFBR2—bone cancer	0.000452	0.0233	CbGpPWpGaD
Carmustine—GSR—Metapathway biotransformation—GSTP1—bone cancer	0.000391	0.0202	CbGpPWpGaD
Carmustine—CYP1A2—Fatty Acid Omega Oxidation—CYP3A4—bone cancer	0.000381	0.0197	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—EZH2—bone cancer	0.000361	0.0187	CbGpPWpGaD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—bone cancer	0.000357	0.0185	CbGpPWpGaD
Carmustine—GSR—Selenium Micronutrient Network—PTGS2—bone cancer	0.000351	0.0181	CbGpPWpGaD
Carmustine—CYP1A2—Estrogen metabolism—CYP3A4—bone cancer	0.000347	0.0179	CbGpPWpGaD
Carmustine—CYP1A2—Aflatoxin activation and detoxification—CYP3A4—bone cancer	0.000332	0.0172	CbGpPWpGaD
Carmustine—CYP1A2—Xenobiotics—CYP3A4—bone cancer	0.000319	0.0165	CbGpPWpGaD
Carmustine—CYP1A2—Tamoxifen metabolism—CYP3A4—bone cancer	0.000307	0.0158	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP4V2—bone cancer	0.000284	0.0147	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—GSTP1—bone cancer	0.000281	0.0145	CbGpPWpGaD
Carmustine—GSR—Metabolism—NDUFA12—bone cancer	0.000278	0.0144	CbGpPWpGaD
Carmustine—Coordination abnormal—Doxorubicin—bone cancer	0.00026	0.00225	CcSEcCtD
Carmustine—Neuropathy—Epirubicin—bone cancer	0.000259	0.00224	CcSEcCtD
Carmustine—Neck pain—Doxorubicin—bone cancer	0.000258	0.00224	CcSEcCtD
Carmustine—Sepsis—Methotrexate—bone cancer	0.000256	0.00222	CcSEcCtD
Carmustine—Pulmonary embolism—Doxorubicin—bone cancer	0.000255	0.00221	CcSEcCtD
Carmustine—Injection site reaction—Doxorubicin—bone cancer	0.000254	0.0022	CcSEcCtD
Carmustine—Eye disorder—Cisplatin—bone cancer	0.000252	0.00218	CcSEcCtD
Carmustine—Coma—Epirubicin—bone cancer	0.000252	0.00218	CcSEcCtD
Carmustine—Flushing—Cisplatin—bone cancer	0.00025	0.00217	CcSEcCtD
Carmustine—Neoplasm—Epirubicin—bone cancer	0.000249	0.00216	CcSEcCtD
Carmustine—Thrombophlebitis—Methotrexate—bone cancer	0.000247	0.00214	CcSEcCtD
Carmustine—Diabetes mellitus—Methotrexate—bone cancer	0.000246	0.00213	CcSEcCtD
Carmustine—Candida infection—Doxorubicin—bone cancer	0.000244	0.00211	CcSEcCtD
Carmustine—Skin exfoliation—Doxorubicin—bone cancer	0.000244	0.00211	CcSEcCtD
Carmustine—Arrhythmia—Cisplatin—bone cancer	0.000241	0.00209	CcSEcCtD
Carmustine—Abnormal vision—Epirubicin—bone cancer	0.000241	0.00208	CcSEcCtD
Carmustine—Neuropathy—Doxorubicin—bone cancer	0.00024	0.00208	CcSEcCtD
Carmustine—Sepsis—Epirubicin—bone cancer	0.000239	0.00207	CcSEcCtD
Carmustine—Mental disability—Epirubicin—bone cancer	0.000239	0.00207	CcSEcCtD
Carmustine—Alopecia—Cisplatin—bone cancer	0.000238	0.00206	CcSEcCtD
Carmustine—Erythema—Cisplatin—bone cancer	0.000235	0.00203	CcSEcCtD
Carmustine—Malnutrition—Cisplatin—bone cancer	0.000235	0.00203	CcSEcCtD
Carmustine—Coma—Doxorubicin—bone cancer	0.000233	0.00202	CcSEcCtD
Carmustine—Phlebitis—Epirubicin—bone cancer	0.000232	0.00201	CcSEcCtD
Carmustine—Thrombophlebitis—Epirubicin—bone cancer	0.000231	0.002	CcSEcCtD
Carmustine—Neoplasm—Doxorubicin—bone cancer	0.000231	0.002	CcSEcCtD
Carmustine—Diabetes mellitus—Epirubicin—bone cancer	0.00023	0.00199	CcSEcCtD
Carmustine—GSR—Metabolism—NT5C3A—bone cancer	0.00023	0.0119	CbGpPWpGaD
Carmustine—Abnormal vision—Doxorubicin—bone cancer	0.000223	0.00193	CcSEcCtD
Carmustine—Eye pain—Epirubicin—bone cancer	0.000222	0.00192	CcSEcCtD
Carmustine—Sepsis—Doxorubicin—bone cancer	0.000221	0.00192	CcSEcCtD
Carmustine—Mental disability—Doxorubicin—bone cancer	0.000221	0.00192	CcSEcCtD
Carmustine—Vision blurred—Cisplatin—bone cancer	0.000221	0.00192	CcSEcCtD
Carmustine—Tremor—Cisplatin—bone cancer	0.00022	0.00191	CcSEcCtD
Carmustine—Anaemia—Cisplatin—bone cancer	0.000217	0.00188	CcSEcCtD
Carmustine—Phlebitis—Doxorubicin—bone cancer	0.000215	0.00186	CcSEcCtD
Carmustine—Thrombophlebitis—Doxorubicin—bone cancer	0.000214	0.00185	CcSEcCtD
Carmustine—Diabetes mellitus—Doxorubicin—bone cancer	0.000213	0.00184	CcSEcCtD
Carmustine—Leukopenia—Cisplatin—bone cancer	0.00021	0.00182	CcSEcCtD
Carmustine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP3A4—bone cancer	0.000208	0.0108	CbGpPWpGaD
Carmustine—Eye pain—Doxorubicin—bone cancer	0.000205	0.00178	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—CDK4—bone cancer	0.000204	0.0105	CbGpPWpGaD
Carmustine—Convulsion—Cisplatin—bone cancer	0.000203	0.00176	CcSEcCtD
Carmustine—Ataxia—Methotrexate—bone cancer	0.000201	0.00174	CcSEcCtD
Carmustine—Hyponatraemia—Epirubicin—bone cancer	0.000201	0.00174	CcSEcCtD
Carmustine—Diplopia—Epirubicin—bone cancer	0.0002	0.00173	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Epirubicin—bone cancer	0.0002	0.00173	CcSEcCtD
Carmustine—Myalgia—Cisplatin—bone cancer	0.0002	0.00173	CcSEcCtD
Carmustine—Anxiety—Cisplatin—bone cancer	0.000199	0.00173	CcSEcCtD
Carmustine—Liver function test abnormal—Methotrexate—bone cancer	0.000197	0.00171	CcSEcCtD
Carmustine—Face oedema—Epirubicin—bone cancer	0.000193	0.00167	CcSEcCtD
Carmustine—Oedema—Cisplatin—bone cancer	0.000192	0.00166	CcSEcCtD
Carmustine—Infection—Cisplatin—bone cancer	0.00019	0.00165	CcSEcCtD
Carmustine—Ataxia—Epirubicin—bone cancer	0.000188	0.00163	CcSEcCtD
Carmustine—Thrombocytopenia—Cisplatin—bone cancer	0.000188	0.00163	CcSEcCtD
Carmustine—Tachycardia—Cisplatin—bone cancer	0.000187	0.00162	CcSEcCtD
Carmustine—Hyponatraemia—Doxorubicin—bone cancer	0.000186	0.00161	CcSEcCtD
Carmustine—Gastrointestinal haemorrhage—Doxorubicin—bone cancer	0.000185	0.0016	CcSEcCtD
Carmustine—Diplopia—Doxorubicin—bone cancer	0.000185	0.0016	CcSEcCtD
Carmustine—Liver function test abnormal—Epirubicin—bone cancer	0.000185	0.0016	CcSEcCtD
Carmustine—Anorexia—Cisplatin—bone cancer	0.000183	0.00158	CcSEcCtD
Carmustine—Hypokalaemia—Epirubicin—bone cancer	0.000182	0.00158	CcSEcCtD
Carmustine—CYP1A2—Estrogen Receptor Pathway—JUN—bone cancer	0.00018	0.00929	CbGpPWpGaD
Carmustine—Hypotension—Cisplatin—bone cancer	0.000179	0.00155	CcSEcCtD
Carmustine—Face oedema—Doxorubicin—bone cancer	0.000179	0.00155	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—RB1—bone cancer	0.000177	0.00916	CbGpPWpGaD
Carmustine—Muscular weakness—Epirubicin—bone cancer	0.000177	0.00153	CcSEcCtD
Carmustine—Pancytopenia—Methotrexate—bone cancer	0.000176	0.00152	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Cisplatin—bone cancer	0.000175	0.00151	CcSEcCtD
Carmustine—Ataxia—Doxorubicin—bone cancer	0.000174	0.00151	CcSEcCtD
Carmustine—Dysphagia—Epirubicin—bone cancer	0.000173	0.0015	CcSEcCtD
Carmustine—Neutropenia—Methotrexate—bone cancer	0.000173	0.0015	CcSEcCtD
Carmustine—Paraesthesia—Cisplatin—bone cancer	0.000172	0.00149	CcSEcCtD
Carmustine—Liver function test abnormal—Doxorubicin—bone cancer	0.000171	0.00148	CcSEcCtD
Carmustine—Dyspnoea—Cisplatin—bone cancer	0.000171	0.00148	CcSEcCtD
Carmustine—Hypokalaemia—Doxorubicin—bone cancer	0.000169	0.00146	CcSEcCtD
Carmustine—Decreased appetite—Cisplatin—bone cancer	0.000167	0.00144	CcSEcCtD
Carmustine—Pneumonia—Methotrexate—bone cancer	0.000166	0.00144	CcSEcCtD
Carmustine—Gastrointestinal disorder—Cisplatin—bone cancer	0.000165	0.00143	CcSEcCtD
Carmustine—Depression—Methotrexate—bone cancer	0.000164	0.00142	CcSEcCtD
Carmustine—Pancytopenia—Epirubicin—bone cancer	0.000164	0.00142	CcSEcCtD
Carmustine—Pain—Cisplatin—bone cancer	0.000164	0.00142	CcSEcCtD
Carmustine—CYP1A2—Tryptophan metabolism—CYP3A4—bone cancer	0.000164	0.00846	CbGpPWpGaD
Carmustine—Muscular weakness—Doxorubicin—bone cancer	0.000163	0.00142	CcSEcCtD
Carmustine—Renal failure—Methotrexate—bone cancer	0.000162	0.0014	CcSEcCtD
Carmustine—Neutropenia—Epirubicin—bone cancer	0.000162	0.0014	CcSEcCtD
Carmustine—Stomatitis—Methotrexate—bone cancer	0.000161	0.00139	CcSEcCtD
Carmustine—Dysphagia—Doxorubicin—bone cancer	0.00016	0.00139	CcSEcCtD
Carmustine—Feeling abnormal—Cisplatin—bone cancer	0.000158	0.00137	CcSEcCtD
Carmustine—Hyperglycaemia—Epirubicin—bone cancer	0.000156	0.00135	CcSEcCtD
Carmustine—Pneumonia—Epirubicin—bone cancer	0.000155	0.00134	CcSEcCtD
Carmustine—Pancytopenia—Doxorubicin—bone cancer	0.000152	0.00132	CcSEcCtD
Carmustine—Renal failure—Epirubicin—bone cancer	0.000152	0.00131	CcSEcCtD
Carmustine—Body temperature increased—Cisplatin—bone cancer	0.000151	0.00131	CcSEcCtD
Carmustine—Neuropathy peripheral—Epirubicin—bone cancer	0.000151	0.00131	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—MDM2—bone cancer	0.000151	0.00781	CbGpPWpGaD
Carmustine—Stomatitis—Epirubicin—bone cancer	0.00015	0.0013	CcSEcCtD
Carmustine—Urinary tract infection—Epirubicin—bone cancer	0.00015	0.0013	CcSEcCtD
Carmustine—Neutropenia—Doxorubicin—bone cancer	0.00015	0.0013	CcSEcCtD
Carmustine—Haemoglobin—Methotrexate—bone cancer	0.000149	0.00129	CcSEcCtD
Carmustine—Haemorrhage—Methotrexate—bone cancer	0.000148	0.00128	CcSEcCtD
Carmustine—Hyperglycaemia—Doxorubicin—bone cancer	0.000144	0.00125	CcSEcCtD
Carmustine—Pneumonia—Doxorubicin—bone cancer	0.000144	0.00124	CcSEcCtD
Carmustine—Visual impairment—Methotrexate—bone cancer	0.000143	0.00124	CcSEcCtD
Carmustine—Hypersensitivity—Cisplatin—bone cancer	0.000141	0.00122	CcSEcCtD
Carmustine—Renal failure—Doxorubicin—bone cancer	0.00014	0.00122	CcSEcCtD
Carmustine—Neuropathy peripheral—Doxorubicin—bone cancer	0.00014	0.00121	CcSEcCtD
Carmustine—Haemoglobin—Epirubicin—bone cancer	0.000139	0.00121	CcSEcCtD
Carmustine—Stomatitis—Doxorubicin—bone cancer	0.000139	0.00121	CcSEcCtD
Carmustine—Urinary tract infection—Doxorubicin—bone cancer	0.000139	0.0012	CcSEcCtD
Carmustine—Haemorrhage—Epirubicin—bone cancer	0.000138	0.0012	CcSEcCtD
Carmustine—Eye disorder—Methotrexate—bone cancer	0.000138	0.0012	CcSEcCtD
Carmustine—Hypoaesthesia—Epirubicin—bone cancer	0.000138	0.00119	CcSEcCtD
Carmustine—Asthenia—Cisplatin—bone cancer	0.000137	0.00119	CcSEcCtD
Carmustine—Oedema peripheral—Epirubicin—bone cancer	0.000136	0.00118	CcSEcCtD
Carmustine—Connective tissue disorder—Epirubicin—bone cancer	0.000136	0.00118	CcSEcCtD
Carmustine—Visual impairment—Epirubicin—bone cancer	0.000133	0.00116	CcSEcCtD
Carmustine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP3A4—bone cancer	0.000132	0.00684	CbGpPWpGaD
Carmustine—GSR—Cellular responses to stress—JUN—bone cancer	0.000131	0.00679	CbGpPWpGaD
Carmustine—Diarrhoea—Cisplatin—bone cancer	0.000131	0.00114	CcSEcCtD
Carmustine—Alopecia—Methotrexate—bone cancer	0.000131	0.00113	CcSEcCtD
Carmustine—CYP1A2—Oxidation by Cytochrome P450—CYP3A4—bone cancer	0.000131	0.00675	CbGpPWpGaD
Carmustine—Mental disorder—Methotrexate—bone cancer	0.00013	0.00112	CcSEcCtD
Carmustine—Eye disorder—Epirubicin—bone cancer	0.000129	0.00112	CcSEcCtD
Carmustine—Malnutrition—Methotrexate—bone cancer	0.000129	0.00112	CcSEcCtD
Carmustine—Erythema—Methotrexate—bone cancer	0.000129	0.00112	CcSEcCtD
Carmustine—Haemoglobin—Doxorubicin—bone cancer	0.000129	0.00112	CcSEcCtD
Carmustine—Flushing—Epirubicin—bone cancer	0.000129	0.00111	CcSEcCtD
Carmustine—Haemorrhage—Doxorubicin—bone cancer	0.000128	0.00111	CcSEcCtD
Carmustine—Hypoaesthesia—Doxorubicin—bone cancer	0.000127	0.0011	CcSEcCtD
Carmustine—Oedema peripheral—Doxorubicin—bone cancer	0.000126	0.00109	CcSEcCtD
Carmustine—Connective tissue disorder—Doxorubicin—bone cancer	0.000126	0.00109	CcSEcCtD
Carmustine—Back pain—Methotrexate—bone cancer	0.000125	0.00108	CcSEcCtD
Carmustine—Arrhythmia—Epirubicin—bone cancer	0.000124	0.00107	CcSEcCtD
Carmustine—Visual impairment—Doxorubicin—bone cancer	0.000123	0.00107	CcSEcCtD
Carmustine—Alopecia—Epirubicin—bone cancer	0.000122	0.00106	CcSEcCtD
Carmustine—Vomiting—Cisplatin—bone cancer	0.000122	0.00106	CcSEcCtD
Carmustine—Vision blurred—Methotrexate—bone cancer	0.000121	0.00105	CcSEcCtD
Carmustine—Mental disorder—Epirubicin—bone cancer	0.000121	0.00105	CcSEcCtD
Carmustine—Rash—Cisplatin—bone cancer	0.000121	0.00105	CcSEcCtD
Carmustine—Dermatitis—Cisplatin—bone cancer	0.000121	0.00105	CcSEcCtD
Carmustine—Erythema—Epirubicin—bone cancer	0.000121	0.00104	CcSEcCtD
Carmustine—Malnutrition—Epirubicin—bone cancer	0.000121	0.00104	CcSEcCtD
Carmustine—Eye disorder—Doxorubicin—bone cancer	0.00012	0.00104	CcSEcCtD
Carmustine—Anaemia—Methotrexate—bone cancer	0.000119	0.00103	CcSEcCtD
Carmustine—Flushing—Doxorubicin—bone cancer	0.000119	0.00103	CcSEcCtD
Carmustine—Back pain—Epirubicin—bone cancer	0.000117	0.00101	CcSEcCtD
Carmustine—Leukopenia—Methotrexate—bone cancer	0.000115	0.000999	CcSEcCtD
Carmustine—Arrhythmia—Doxorubicin—bone cancer	0.000114	0.000992	CcSEcCtD
Carmustine—Nausea—Cisplatin—bone cancer	0.000114	0.000986	CcSEcCtD
Carmustine—Vision blurred—Epirubicin—bone cancer	0.000114	0.000984	CcSEcCtD
Carmustine—Alopecia—Doxorubicin—bone cancer	0.000113	0.000981	CcSEcCtD
Carmustine—Mental disorder—Doxorubicin—bone cancer	0.000112	0.000973	CcSEcCtD
Carmustine—Convulsion—Methotrexate—bone cancer	0.000112	0.000967	CcSEcCtD
Carmustine—Erythema—Doxorubicin—bone cancer	0.000112	0.000966	CcSEcCtD
Carmustine—Malnutrition—Doxorubicin—bone cancer	0.000112	0.000966	CcSEcCtD
Carmustine—Anaemia—Epirubicin—bone cancer	0.000111	0.000965	CcSEcCtD
Carmustine—Agitation—Epirubicin—bone cancer	0.000111	0.00096	CcSEcCtD
Carmustine—Chest pain—Methotrexate—bone cancer	0.00011	0.00095	CcSEcCtD
Carmustine—Myalgia—Methotrexate—bone cancer	0.00011	0.00095	CcSEcCtD
Carmustine—Leukopenia—Epirubicin—bone cancer	0.000108	0.000935	CcSEcCtD
Carmustine—Back pain—Doxorubicin—bone cancer	0.000108	0.000935	CcSEcCtD
Carmustine—CYP1A2—Phase 1 - Functionalization of compounds—CYP3A4—bone cancer	0.000107	0.00555	CbGpPWpGaD
Carmustine—Confusional state—Methotrexate—bone cancer	0.000106	0.000918	CcSEcCtD
Carmustine—Vision blurred—Doxorubicin—bone cancer	0.000105	0.000911	CcSEcCtD
Carmustine—Convulsion—Epirubicin—bone cancer	0.000104	0.000905	CcSEcCtD
Carmustine—Infection—Methotrexate—bone cancer	0.000104	0.000905	CcSEcCtD
Carmustine—Hypertension—Epirubicin—bone cancer	0.000104	0.000902	CcSEcCtD
Carmustine—Anaemia—Doxorubicin—bone cancer	0.000103	0.000893	CcSEcCtD
Carmustine—Thrombocytopenia—Methotrexate—bone cancer	0.000103	0.000892	CcSEcCtD
Carmustine—Chest pain—Epirubicin—bone cancer	0.000103	0.000889	CcSEcCtD
Carmustine—Myalgia—Epirubicin—bone cancer	0.000103	0.000889	CcSEcCtD
Carmustine—Agitation—Doxorubicin—bone cancer	0.000103	0.000888	CcSEcCtD
Carmustine—Anxiety—Epirubicin—bone cancer	0.000102	0.000886	CcSEcCtD
Carmustine—GSR—Metabolism—ENO2—bone cancer	0.000101	0.00521	CbGpPWpGaD
Carmustine—Anorexia—Methotrexate—bone cancer	0.0001	0.000868	CcSEcCtD
Carmustine—Leukopenia—Doxorubicin—bone cancer	9.98e-05	0.000865	CcSEcCtD
Carmustine—Confusional state—Epirubicin—bone cancer	9.92e-05	0.000859	CcSEcCtD
Carmustine—Oedema—Epirubicin—bone cancer	9.84e-05	0.000852	CcSEcCtD
Carmustine—Hypotension—Methotrexate—bone cancer	9.82e-05	0.000851	CcSEcCtD
Carmustine—Infection—Epirubicin—bone cancer	9.77e-05	0.000847	CcSEcCtD
Carmustine—Convulsion—Doxorubicin—bone cancer	9.66e-05	0.000837	CcSEcCtD
Carmustine—Thrombocytopenia—Epirubicin—bone cancer	9.63e-05	0.000835	CcSEcCtD
Carmustine—Hypertension—Doxorubicin—bone cancer	9.63e-05	0.000834	CcSEcCtD
Carmustine—Tachycardia—Epirubicin—bone cancer	9.6e-05	0.000832	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Methotrexate—bone cancer	9.58e-05	0.00083	CcSEcCtD
Carmustine—Insomnia—Methotrexate—bone cancer	9.51e-05	0.000824	CcSEcCtD
Carmustine—Chest pain—Doxorubicin—bone cancer	9.5e-05	0.000823	CcSEcCtD
Carmustine—Myalgia—Doxorubicin—bone cancer	9.5e-05	0.000823	CcSEcCtD
Carmustine—Anxiety—Doxorubicin—bone cancer	9.46e-05	0.00082	CcSEcCtD
Carmustine—Paraesthesia—Methotrexate—bone cancer	9.44e-05	0.000818	CcSEcCtD
Carmustine—Anorexia—Epirubicin—bone cancer	9.38e-05	0.000812	CcSEcCtD
Carmustine—Dyspnoea—Methotrexate—bone cancer	9.37e-05	0.000812	CcSEcCtD
Carmustine—Somnolence—Methotrexate—bone cancer	9.35e-05	0.00081	CcSEcCtD
Carmustine—GSR—Metabolism—DHFR—bone cancer	9.35e-05	0.00483	CbGpPWpGaD
Carmustine—Hypotension—Epirubicin—bone cancer	9.19e-05	0.000796	CcSEcCtD
Carmustine—Confusional state—Doxorubicin—bone cancer	9.18e-05	0.000795	CcSEcCtD
Carmustine—Decreased appetite—Methotrexate—bone cancer	9.14e-05	0.000792	CcSEcCtD
Carmustine—Oedema—Doxorubicin—bone cancer	9.1e-05	0.000789	CcSEcCtD
Carmustine—Gastrointestinal disorder—Methotrexate—bone cancer	9.08e-05	0.000786	CcSEcCtD
Carmustine—Infection—Doxorubicin—bone cancer	9.04e-05	0.000783	CcSEcCtD
Carmustine—Pain—Methotrexate—bone cancer	8.99e-05	0.000779	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Epirubicin—bone cancer	8.96e-05	0.000777	CcSEcCtD
Carmustine—Thrombocytopenia—Doxorubicin—bone cancer	8.91e-05	0.000772	CcSEcCtD
Carmustine—Insomnia—Epirubicin—bone cancer	8.9e-05	0.000771	CcSEcCtD
Carmustine—Tachycardia—Doxorubicin—bone cancer	8.89e-05	0.00077	CcSEcCtD
Carmustine—Paraesthesia—Epirubicin—bone cancer	8.83e-05	0.000765	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—RB1—bone cancer	8.82e-05	0.00456	CbGpPWpGaD
Carmustine—Dyspnoea—Epirubicin—bone cancer	8.77e-05	0.00076	CcSEcCtD
Carmustine—Somnolence—Epirubicin—bone cancer	8.75e-05	0.000758	CcSEcCtD
Carmustine—GSR—Metabolism—GNA11—bone cancer	8.74e-05	0.00452	CbGpPWpGaD
Carmustine—Anorexia—Doxorubicin—bone cancer	8.68e-05	0.000752	CcSEcCtD
Carmustine—GSR—Cellular responses to stress—TP53—bone cancer	8.67e-05	0.00448	CbGpPWpGaD
Carmustine—Feeling abnormal—Methotrexate—bone cancer	8.66e-05	0.000751	CcSEcCtD
Carmustine—Gastrointestinal pain—Methotrexate—bone cancer	8.6e-05	0.000745	CcSEcCtD
Carmustine—Decreased appetite—Epirubicin—bone cancer	8.55e-05	0.000741	CcSEcCtD
Carmustine—Hypotension—Doxorubicin—bone cancer	8.51e-05	0.000737	CcSEcCtD
Carmustine—Gastrointestinal disorder—Epirubicin—bone cancer	8.49e-05	0.000736	CcSEcCtD
Carmustine—Pain—Epirubicin—bone cancer	8.41e-05	0.000729	CcSEcCtD
Carmustine—Constipation—Epirubicin—bone cancer	8.41e-05	0.000729	CcSEcCtD
Carmustine—CYP1A2—Phase II conjugation—GSTP1—bone cancer	8.33e-05	0.00431	CbGpPWpGaD
Carmustine—Body temperature increased—Methotrexate—bone cancer	8.31e-05	0.00072	CcSEcCtD
Carmustine—Abdominal pain—Methotrexate—bone cancer	8.31e-05	0.00072	CcSEcCtD
Carmustine—Musculoskeletal discomfort—Doxorubicin—bone cancer	8.29e-05	0.000719	CcSEcCtD
Carmustine—Insomnia—Doxorubicin—bone cancer	8.23e-05	0.000713	CcSEcCtD
Carmustine—Paraesthesia—Doxorubicin—bone cancer	8.17e-05	0.000708	CcSEcCtD
Carmustine—Dyspnoea—Doxorubicin—bone cancer	8.12e-05	0.000703	CcSEcCtD
Carmustine—Feeling abnormal—Epirubicin—bone cancer	8.11e-05	0.000702	CcSEcCtD
Carmustine—Somnolence—Doxorubicin—bone cancer	8.09e-05	0.000701	CcSEcCtD
Carmustine—Gastrointestinal pain—Epirubicin—bone cancer	8.05e-05	0.000697	CcSEcCtD
Carmustine—GSR—Metabolism—CYP3A4—bone cancer	7.92e-05	0.00409	CbGpPWpGaD
Carmustine—Decreased appetite—Doxorubicin—bone cancer	7.91e-05	0.000686	CcSEcCtD
Carmustine—Gastrointestinal disorder—Doxorubicin—bone cancer	7.86e-05	0.000681	CcSEcCtD
Carmustine—Pain—Doxorubicin—bone cancer	7.79e-05	0.000674	CcSEcCtD
Carmustine—Constipation—Doxorubicin—bone cancer	7.79e-05	0.000674	CcSEcCtD
Carmustine—Abdominal pain—Epirubicin—bone cancer	7.78e-05	0.000674	CcSEcCtD
Carmustine—Body temperature increased—Epirubicin—bone cancer	7.78e-05	0.000674	CcSEcCtD
Carmustine—Hypersensitivity—Methotrexate—bone cancer	7.75e-05	0.000671	CcSEcCtD
Carmustine—Asthenia—Methotrexate—bone cancer	7.54e-05	0.000653	CcSEcCtD
Carmustine—CYP1A2—Tryptophan metabolism—MDM2—bone cancer	7.52e-05	0.00389	CbGpPWpGaD
Carmustine—Feeling abnormal—Doxorubicin—bone cancer	7.5e-05	0.00065	CcSEcCtD
Carmustine—Gastrointestinal pain—Doxorubicin—bone cancer	7.44e-05	0.000645	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—bone cancer	7.25e-05	0.00375	CbGpPWpGaD
Carmustine—Hypersensitivity—Epirubicin—bone cancer	7.25e-05	0.000628	CcSEcCtD
Carmustine—Body temperature increased—Doxorubicin—bone cancer	7.2e-05	0.000623	CcSEcCtD
Carmustine—Abdominal pain—Doxorubicin—bone cancer	7.2e-05	0.000623	CcSEcCtD
Carmustine—Diarrhoea—Methotrexate—bone cancer	7.19e-05	0.000623	CcSEcCtD
Carmustine—Asthenia—Epirubicin—bone cancer	7.06e-05	0.000612	CcSEcCtD
Carmustine—Dizziness—Methotrexate—bone cancer	6.95e-05	0.000602	CcSEcCtD
Carmustine—CYP1A2—Arachidonic acid metabolism—PTGS2—bone cancer	6.79e-05	0.00351	CbGpPWpGaD
Carmustine—GSR—Metabolism—GSTP1—bone cancer	6.77e-05	0.0035	CbGpPWpGaD
Carmustine—Diarrhoea—Epirubicin—bone cancer	6.73e-05	0.000583	CcSEcCtD
Carmustine—Hypersensitivity—Doxorubicin—bone cancer	6.71e-05	0.000581	CcSEcCtD
Carmustine—Vomiting—Methotrexate—bone cancer	6.68e-05	0.000579	CcSEcCtD
Carmustine—Rash—Methotrexate—bone cancer	6.63e-05	0.000574	CcSEcCtD
Carmustine—Dermatitis—Methotrexate—bone cancer	6.62e-05	0.000574	CcSEcCtD
Carmustine—Headache—Methotrexate—bone cancer	6.59e-05	0.000571	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—bone cancer	6.54e-05	0.00338	CbGpPWpGaD
Carmustine—Asthenia—Doxorubicin—bone cancer	6.53e-05	0.000566	CcSEcCtD
Carmustine—Dizziness—Epirubicin—bone cancer	6.51e-05	0.000564	CcSEcCtD
Carmustine—Vomiting—Epirubicin—bone cancer	6.26e-05	0.000542	CcSEcCtD
Carmustine—Nausea—Methotrexate—bone cancer	6.24e-05	0.000541	CcSEcCtD
Carmustine—Diarrhoea—Doxorubicin—bone cancer	6.23e-05	0.00054	CcSEcCtD
Carmustine—Rash—Epirubicin—bone cancer	6.2e-05	0.000537	CcSEcCtD
Carmustine—Dermatitis—Epirubicin—bone cancer	6.2e-05	0.000537	CcSEcCtD
Carmustine—Headache—Epirubicin—bone cancer	6.16e-05	0.000534	CcSEcCtD
Carmustine—Dizziness—Doxorubicin—bone cancer	6.02e-05	0.000522	CcSEcCtD
Carmustine—Nausea—Epirubicin—bone cancer	5.84e-05	0.000506	CcSEcCtD
Carmustine—Vomiting—Doxorubicin—bone cancer	5.79e-05	0.000501	CcSEcCtD
Carmustine—Rash—Doxorubicin—bone cancer	5.74e-05	0.000497	CcSEcCtD
Carmustine—Dermatitis—Doxorubicin—bone cancer	5.73e-05	0.000497	CcSEcCtD
Carmustine—Headache—Doxorubicin—bone cancer	5.7e-05	0.000494	CcSEcCtD
Carmustine—CYP1A2—Biological oxidations—CYP3A4—bone cancer	5.7e-05	0.00295	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—CYP3A4—bone cancer	5.62e-05	0.00291	CbGpPWpGaD
Carmustine—Nausea—Doxorubicin—bone cancer	5.41e-05	0.000468	CcSEcCtD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bone cancer	5.14e-05	0.00266	CbGpPWpGaD
Carmustine—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bone cancer	5.14e-05	0.00266	CbGpPWpGaD
Carmustine—CYP1A2—Biological oxidations—GSTP1—bone cancer	4.87e-05	0.00252	CbGpPWpGaD
Carmustine—CYP1A2—Metapathway biotransformation—GSTP1—bone cancer	4.81e-05	0.00249	CbGpPWpGaD
Carmustine—GSR—Metabolism—PTGS2—bone cancer	3.51e-05	0.00181	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NDUFA12—bone cancer	3.42e-05	0.00177	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—NT5C3A—bone cancer	2.83e-05	0.00146	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—ENO2—bone cancer	1.24e-05	0.000641	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—DHFR—bone cancer	1.15e-05	0.000595	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GNA11—bone cancer	1.08e-05	0.000556	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—CYP3A4—bone cancer	9.75e-06	0.000504	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bone cancer	9.7e-06	0.000501	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—GSTP1—bone cancer	8.34e-06	0.000431	CbGpPWpGaD
Carmustine—CYP1A2—Metabolism—PTGS2—bone cancer	4.32e-06	0.000223	CbGpPWpGaD
